Background and Purpose: Natriuretic peptides have led the way as a diagnostic and
prognostic tool for the diagnosis and management of heart failure (HF). More recent …

Cardiac troponin testing is commonly performed in patients with heart failure (HF). Despite
being strongly linked to spontaneous (Type I) acute myocardial infarction (MI)—a common …

Background Cardiac troponin provides diagnostic and prognostic information in acute
coronary syndromes, but its role in acute decompensated heart failure is unclear. The …

Cardiac troponin‐I (cTnI) is a highly sensitive and specific marker of myocardial injury and
can be detected in plasma by immunoassay techniques. The purpose of this study was to …

Background—Cardiac troponin T (cTnT) and B-type natriuretic peptide (BNP) have been
used to estimate prognosis in heart failure; however, most studies have evaluated …

Background—The progression of chronic heart failure (CHF) is related to ongoing myocyte
loss, which can be detected by cardiac troponin T (cTnT). We examined the prevalence and …

BACKGROUND: Troponin level elevations are common in patients with acute
decompensated heart failure (ADHF), yet their prognostic value above and beyond …

Cardiac troponin (cTn) is the primary biomarker for the diagnosis of myocardial necrosis in
an acute coronary syndrome (ACS). cTn levels can also be elevated in many other …

Objectives: The purpose of this study was to determine whether different profiles of cardiac
troponin T (cTnT) values assessed over time would yield incremental prognostic information …

Thrombotic events (coronary thrombosis, venous thromboembolism, intraventricular
thrombosis, intracranial and systemic thromboembolism) occur frequently in patients with …